BioArctic AB: Number of Shares and Votes as of August 31, 2026

BioArctic AB (publ) announced on August 31, 2026, that the company issued 20,200 Class B shares during August. These shares were delivered to participants in the 2019/2028 stock option program, which was resolved at the Annual General Meeting on May 9, 2019.

As a result of these transactions, the company's share capital has increased. The total number of shares in BioArctic now stands at 118,322,098, consisting of 3,648,784 Class A shares and 114,673,314 Class B shares. The total voting rights in the company amount to 151,161,154.

BioArctic is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. The company's pipeline includes therapies targeting conditions such as Alzheimer's disease and Parkinson's disease.